Ward Doelman

Ward Doelman

Auto-generated profile, based on publicly available information

Ward Doelman

Department of Chemical Biology and Immunology, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
RRRoger Riera
Roger Riera
THTim P. Hogervorst
Tim P. Hogervorst
WDWard Doelman
Ward Doelman
YNYan Ni
Yan Ni
SRSílvia Pujals Riatos
Sílvia Pujals Riatos
LALorenzo Albertazzi
Lorenzo Albertazzi

8 November 2018 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
ASAlexi J. C. Sarris
Alexi J. C. Sarris
THThomas Hansen
Thomas Hansen
MGMark A. R. de Geus
Mark A. R. de Geus
EMElmer Maurits
Elmer Maurits
WDWard Doelman
Ward Doelman
SKSander I. van Kasteren
Sander I. van Kasteren

29 July 2022 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
WDWard Doelman
Ward Doelman
SKSander I. van Kasteren
Sander I. van Kasteren
Synthetic glycopeptides are of key importance for unraveling the complexities of glycobiology. In this Review, the key approaches towards synthetic well-defined glycopeptides and glycopeptide conjugates are described.

1 June 2018 in Biochemical Pharmacology
Verified
Journal Article
Open access
MSMarjolein Soethoudt
Marjolein Soethoudt
MHMark W.H. Hoorens
Mark W.H. Hoorens
WDWard Doelman
Ward Doelman
AMAndrea Martella
Andrea Martella
MSMario van der Stelt
Mario van der Stelt
LHLaura Heitman
Laura Heitman
A decade ago, the drug-target residence time model has been (re-)introduced, which describes the importance of binding kinetics of ligands on their protein targets. Since then, it has been applied successfully for multiple protein targets, including GPCRs, for the development of lead compounds with slow dissociation kinetics (i.e. long target residence time) to increase in vivo efficacy or with short residence time to prevent on-target associated side effects. To date, this model has not been applied in the design and pharmacological evaluation of novel selective ligands for the cannabinoid CB2 receptor (CB2R), a GPCR with therapeutic potential in the treatment of tissue injury and inflammatory diseases. Here, we have investigated the relationships between physicochemical properties, binding kinetics and functional activity in two different signal transduction pathways, G protein activation and β-arrestin recruitment. We synthesized 24 analogues of 3-cyclopropyl-1-(4-(6-((1,1-dioxidothiomorpholino)methyl)-5-fluoropyridin-2-yl)benzyl)imidazoleidine-2,4-dione (LEI101), our previously reported in vivo active and CB2R-selective agonist, with varying basicity and lipophilicity. We identified a positive correlation between target residence time and functional potency due to an increase in lipophilicity on the alkyl substituents, which was not the case for the amine substituents. Basicity of the agonists did not show a relationship with affinity, residence time or functional activity. Our findings provide important insights about the effects of physicochemical properties of the specific substituents of this scaffold on the binding kinetics of agonists and their CB2R pharmacology. This work therefore shows how CB2R agonists can be designed to have optimal kinetic profiles, which could aid the lead optimization process in drug discovery for the study or treatment of inflammatory diseases.

4 December 2018 in Biochemistry
Verified
Journal Article
Open access
CACan Araman
Can Araman
MGMiriam E. van Gent
Miriam E. van Gent
NMNico J. Meeuwenoord
Nico J. Meeuwenoord
NHNicole Heijmans
Nicole Heijmans
MMMikkel H. S. Marqvorsen
Mikkel H. S. Marqvorsen
SKSander I. Van Kasteren
Sander I. Van Kasteren
Multiple Sclerosis (MS) is an autoimmune disorder manifested via chronic inflammation, demyelination and neurodegeneration inside the central nervous system (CNS). The progressive phase of MS is characterized by neurodegeneration, but unlike classical neurodegenerative diseases, amyloid-like aggregation of self-proteins has not been documented. There is evidence that citrullination protects an immunodominant peptide of human myelin oligodendrocyte glycoprotein (MOG34-56) against destructive processing in EBV-infected B-lymphocytes (EBV-BLCs) in marmosets and causes exacerbation of ongoing MS-like encephalopathies in mice. Here we collected evidence that citrullination of MOG can also lead to amyloid-like behavior shifting the disease pathogenesis towards neurodegeneration. We observed that an immunodominant MOG peptide, MOG35-55, displays amyloid-like behavior upon site-specific citrullination at positions 41, 46 and/or 52. These amyloid aggregates are shown to be toxic to the EBV-BLCs, and to dendritic cells, at concentrations favored for antigen presentation suggesting a role of amyloid-like aggregation in the pathogenesis of progressive MS.

17 April 2019 in Chemical Communications
Verified
Journal Article
Open access
PDF file
MMMikkel Haarslev Schröder Marqvorsen
Mikkel Haarslev Schröder Marqvorsen
SPSivasinthujah Paramasivam
Sivasinthujah Paramasivam
WDWard Doelman
Ward Doelman
AFAntony John Fairbanks
Antony John Fairbanks
SKSander Izaäk van Kasteren
Sander Izaäk van Kasteren
N-Azidoacetyl-D-glucosamine (GlcNAz) is a particularly useful tool in chemical biology as the azide is a metabolically stable yet accessible handle within biological systems. Herein, we report a practical synthesis of FmocAsn(N-Ac3GlcNAz)OH, a building block for solid phase peptide synthesis (SPPS). Protecting group manipulations are minimised by taking advantage of the inherent chemoselectivity of phosphine-mediated azide reduction, and the resulting glycosyl amine is employed directly in the opening of Fmoc protected aspartic anhydride. We show potential application of the building block by establishing it as a substrate for enzymatic glycan extension using sugar oxazolines of varying size and biological significance with several endo-β-N-acetylglucosaminidases (ENGases). The added steric bulk resulting from incorporation of the azide is shown to have no or a minor impact on the yield of enzymatic glycan extension.